EGFR and neoplasm: Therefore, loss of CMTM4 in tumor cells decreased EGFR signaling, and hence, decreased G-CSF production and PMN-MDSCs recruitment, which led to a less suppressive tumor immune microenvironment and reduced tumor growth.